Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARD001 in Healthy Adults and Hemophilia A
NCT07787091Phase 2Recruiting
- Sponsor
- Arditus
- Start
- Aug 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 2 trial of ARD001 in hemophilia A, sponsored by Arditus. Started Aug 2026; status: recruiting.
02
Drugs
ARD001
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT07787091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07787091.